Apyx Medical Corporation
APYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.2% | 20.6% | -33.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 64.4% | 62.3% | 60.1% | 63% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.6% | -19% | -27.7% | -19.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15.4% | -33.2% | -44% | -32.5% |
| EPS Diluted | 0 | -0.093 | -0.12 | -0.12 |
| % Growth | 100% | 22.7% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |